WHO prequalifies arthritis drug for severe COVID cases
The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.
Feb 11, 2022
0
13